Par Pharmaceutical Companies Reports First Quarter 2012 Results - MarketWatch (press release)
Par Pharmaceutical Companies Reports First Quarter 2012 ResultsMarketWatch (press release)Par Pharmaceutical remained the exclusive supplier of generic Rythmol SR® throughout the first quarter.
RAAFT 2: Catheter ablation can be first line of defense against paroxysmal AF - TheHeart.Org
RAAFT 2: Catheter ablation can be first line of defense against paroxysmal AFTheHeart.